US-based Precision Spine has obtained 510(k) approval for its VAULT-C Anterior Cervical Interbody Fusion Device.
The device has been developed to be used by skeletally mature patients with degenerative disc disease (DDD) of the cervical spine (C3-T1)at one disc level.
Precision Spine president Rich Dickerson said the new device will offer surgeons an additional treatment option, allowing for easier access to challenging levels of the cervical spine, with a true zero profile construct.
"The introduction of the VAULT-C reinforces our continuing commitment to treat the full spectrum of spinal pathologies through ongoing product development and innovation," Dickerson added.
The new device’s plate/cage integrated design helps in rigid screw fixation using a zero profile construct.
According to the company, the zero profile design minimises the risk of damage to surrounding vessels and adjacent soft tissue, while the large and open bone graft area allows for optimal graft containment.
The device is available in different heights and geometric footprints to accommodate individual patient anatomy and desired graft material sizes. It is said to provide mechanical support to the implanted level until biologic fusion is achieved.